Bio-Techne (TECH) Equity Average (2016 - 2025)
Historic Equity Average for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $2.0 billion.
- Bio-Techne's Equity Average fell 569.91% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year decrease of 569.91%. This contributed to the annual value of $2.0 billion for FY2025, which is 118.22% down from last year.
- As of Q4 2025, Bio-Techne's Equity Average stood at $2.0 billion, which was down 569.91% from $1.9 billion recorded in Q3 2025.
- In the past 5 years, Bio-Techne's Equity Average registered a high of $2.1 billion during Q4 2024, and its lowest value of $1.5 billion during Q1 2021.
- In the last 5 years, Bio-Techne's Equity Average had a median value of $1.9 billion in 2023 and averaged $1.9 billion.
- Per our database at Business Quant, Bio-Techne's Equity Average skyrocketed by 1775.33% in 2021 and then crashed by 767.39% in 2025.
- Quarter analysis of 5 years shows Bio-Techne's Equity Average stood at $1.7 billion in 2021, then rose by 6.82% to $1.8 billion in 2022, then grew by 10.7% to $2.0 billion in 2023, then increased by 6.46% to $2.1 billion in 2024, then fell by 5.7% to $2.0 billion in 2025.
- Its last three reported values are $2.0 billion in Q4 2025, $1.9 billion for Q3 2025, and $2.0 billion during Q2 2025.